merger

UTZ BRANDS INC., $16.64, symbol UTZ on New York, is a Pennsylvania-based maker of salty snacks. Its brands include Utz Original potato chips, On the Border Chips & Dips, Zapp’s, Good Health, Boulder Canyon, Tortiyahs, and others.

Founded in 1921, Utz began trading on the New York exchange in June 2020.

Rather than list through an IPO, the company undertook a reverse merger with Collier Creek Holdings....
CN Rail failed in its attempt to buy U.S. railway Kansas City Southern, which will instead merge with Canadian Pacific Railway. Still, following its rejected offer, CN hired a new CEO in January 2022. That move helped kick-start a growth plan for CN, which will increase value for shareholders and satisfy the demands of an activist investor.


Railways are highly cyclical, and the stock has moved mostly sideways since the start of 2022 on concerns rising inflation and interest rates will slow the economy.


However, CN’s long-term outlook remains strong, as its focus on efficiency will keep fuelling its earnings....
A: FactSet Research Systems Inc., $419.92, symbol FDS on New York (Shares outstanding: 38.3 million; Market cap: $16.1 billion; www.factset.com), is a leading provider of financial data and portfolio analytics to investment firms worldwide.

In March 2022, FactSet completed the acquisition of CUSIP Global Services for $1.93 billion in cash....
GEN DIGITAL INC., $21.53, is a buy. The company (Nasdaq symbol GEN; TSINetwork Rating: Extra Risk) (gendigital.com; Shares o/s: 661.0 million; Market cap: $14.2 billion; Divd....
NEWMONT CORP., $47.98, New York symbol NEM, remains a buy, for your long-term growth and as a hedge against inflation.

The stock gives you exposure to the world’s largest gold miner following Newmont’s April 2019 acquisition of Vancouver-based Goldcorp Inc....
CP Rail and Metro are leading competitors in their respective markets; look for that to cut your risk if the economy should weaken. Regardless, we see both stocks as buys.


CANADIAN PACIFIC RAILWAY $103.62, is a buy. The company (Toronto symbol CP; shares o/s: 930.1 million; Market cap: $97.7 billion; Rating: Above Average; Dividend yield: 0.7%) ships freight over a 23,700-kilometre rail network, mainly between Montreal and Vancouver....
Commercial air traffic volumes have now rebounded to 80% of their pre-pandemic levels. That continues to spur demand for Raytheon’s aerospace products. The company’s military businesses also benefit as the U.S. and other NATO countries seek to replenish the stockpile of missiles and other weapons currently being sent to Ukraine to help it repel the Russian invasion....
CORTEVA INC., $62.36, is a buy. The company (symbol CTVA on New York) is a leading developer of new seeds and crop chemicals, including herbicides and insecticides, for the agriculture industry. Corteva separated from DowDuPont in June 2019.

China recently approved imports of eight genetically modified (GM) food crops....
FRESHII INC. $2.26 is a hold. The company (Toronto symbol FRII; Consumer sector; Shares outstanding: 24.2 million; Market cap: $54.7 million; No dividend paid; Takeover Target Rating: Highest; www.freshii.com) operates fast-food restaurants that offer healthful menu options focused on fresh produce and lean proteins.


The company sold shares to the public and began trading on the Toronto Exchange at $11.50 in late January 2017.


Freshii has now accepted a $2.30-a-share takeover offer from Foodtastic Inc., a Montreal-based, privately held franchisor of multiple restaurant brands in Canada....
Spinoffs are a great way for companies to sharpen their focus on the more-profitable segments of their businesses. Here are two recent examples we feel will pay off for investors over the next few years.


BAXTER INTERNATIONAL INC. $44 is a buy. The company (New York symbol BAX; Manufacturing sector; Shares o/s: 504.1 million; Market cap: $22.2 billion; Dividend yield: 2.6%; Takeover Target Rating: Medium; www.baxter.com) makes a variety of medical devices, including intravenous pumps and kidney-dialysis equipment.


Baxter now plans to spin off its Renal Care and Acute Therapies businesses as one separate company....